Calcitonin, hypocalcemia ---> SmPC of [recombinant salmon calcitonin] of EMA
Calcitonin is contraindicated in patients with hypocalcaemia
Delamanid [1], hypocalcemia ---> SmPC of [1] of EMA
Treatment with delamanid should not be initiated in patients with risk factors like electrolyte disturbances, particularly hypokalaemia, hypocalcaemia or hypomagnesaemia unless the possible benefit is considered to outweigh the potential risks.
Etelcalcetide [1], hypocalcemia ---> SmPC of [1] of EMA
Administer Parsabiv with caution in patients receiving any other medicinal products known to lower serum calcium. Closely monitor serum calcium
Foscarnet [1], hypocalcemia ---> SmPC of [1] of eMC
Since foscarnet can reduce serum levels of ionised calcium, extreme caution is advised when used concurrently with other drugs known to influence serum calcium levels, like i.v. pentamidine.
Hypocalcemia, hypocalcemia
Enhancement of the hypocalcemic effect
Hypocalcemia, methadone [2] ---> SmPC of [2] of eMC
Cases of QT interval prolongation and torsade de pointes have been reported during methadone treatment, particularly at high doses (> 100 mg/d). Methadone should be administered with caution to patients at risk of development of prolonged QT interval
Hypocalcemia, pamidronate
Possible hypocalcemia with clinic symptoms (paresthesias, tetania, hypotension)
Hypocalcemia, pamidronic acid
Possible hypocalcemia with clinic symptoms (paresthesias, tetania, hypotension)
Hypocalcemia, posaconazole [2] ---> SmPC of [2] of EMA
Electrolyte disturbances should be monitored and corrected as necessary before and during posaconazole therapy.
Hypocalcemia, selpercatinib [2] ---> SmPC of [2] of EMA
Hypokalaemia, hypomagnesaemia and hypocalcaemia should be corrected prior to initiating selpercatinib and during treatment.
Hypocalcemia, sorafenib [2] ---> SmPC of [2] of EMA
Sorafenib has been shown to prolong the QT/QTc interval, which may lead to an increased risk for ventricular arrhythmias. Use sorafenib with caution in patients who have, or may develop prolongation of QTc
Hypocalcemia, tolterodine [2] ---> SmPC of [2] of eMC
Tolterodine should be used with caution in patients with risk factors for QT-prolongation